Clinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 140, Issue 1, 2008, Pages 82-89

  Takač, Iztok ^a   Uršič Vrščaj, Marjetka ^b   Repše Fokter, Alenka ^c   Kodrič, Tatjana ^a   Rakar, Stelio ^d   Možina, Andrej ^d   Smrkolj, Špela ^d   Primic Žakelj, Maja ^b   Stržinar, Vida ^b   Vakselj, Aleš ^b   Arko, Darja ^a  

^a UNIVERSITY OF MARIBOR   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

^c General Hospital Celje   (Slovenia)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Cervical cancer; Organized screening program; Slovenia

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SLOVENIA; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 49649102107     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.02.019     Document Type: Article

References (25)

1. Milojković M., and Pajtler M. Cytology and cervical cancer. Coll Antropol 28 (2004) 293-300
2. Pohar-Marinšek Z., and Pogačnik A. Cytopathology in Slovenia. Cytopathology 15 (2004) 53-57
3. Primic-Žakelj M., Bračko M., Hočevar M., et al. Cancer incidence in Slovenia 2004 (2007), Onkološki inštitut, Register raka za Slovenijo, Ljubljana pp. 48-68
4. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base No. 5 (2001), IARC Press, Lyon
5. Sant M., Aareleid T., Berrino F., et al., EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 14 Suppl. 5 (2003) 98
6. Uršič-Vrščaj M., Rakar S., Možina A., et al. Clinical audit of patients with cervical cancer in Slovenia-data analysis for the year 2003. Eur J Gynaec Oncol 26 (2005) 537-542
7. Smrkolj S., Rakar S., Možina A., and Eržen M. Evaluation of causes of increased incidence of cervical cancer in Slovenia. Eur J Obstet Gyn RB 117 (2004) 213-221
8. Rebolj M., van Ballegooijen M., Berkers L.M., and Habbemaa D. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 120 (2006) 806-812
9. Antilla A., Ronco G., Clifford G., et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 91 (2004) 935-941
10. International Agency for Research on Cancer. Recommendations for public healt implementation and further research. IARC handbooks on cancer prevention. Vol. 10. Cervix cancer screening (2005), IARC Press, Lyon pp. 239-41
11. Nieminen P., Hakama M., Vikki M., Tarkkanen J., and Anttila A. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year. Int J Cancer 103 (2003) 422-426
12. Milojković M., and Pajtler M. Influence of cytology development on frequency of pre-cancerous lesions and cervical cancer in East Croatia, 1978-2001. Coll Antropol 1 (2004) 293-300
13. Zapka J.G., Taplin S.H., Solberg L.I., and Manos M.M. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev 12 (2003) 4-13
14. Insinga R.P., Glass A.G., and Rush B.B. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol 191 (2004) 105-113
15. Pogačnik A., Kirbiš-Srebotnik I., Repše-Fokter A., et al. Guideliness for uniform cytopathology report (2nd ed.) [in Slovenian] (2005), Institute of Oncology Ljubljana, Ljubljana
16. Uršič-Vrščaj M., Rakar S., Kovačič J., Kralj B., and Možina A. Guidelines for treatment and follow-up of women with precancerous lesions of uterine cervix [in Slovenian] (2000), Medical Chamber of Slovenia, Ljubljana
17. Bulk S., Visser O., Rozendaal L., Verheijen R.H.M., and Meijer C.J.L.M. Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 113 (2005) 1005-1009
18. Chan P.G., Sung H.Y., and Sawaya G.F. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 102 (2003) 765-773
19. Leyden W.A., Manos M., Geiger A.M., et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 97 (2005) 675-683
20. Arbyn M., Buntix F., Van Ranst M., Paraskevaidis E., Martin-Hirsch P., and Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 96 (2004) 280-293
21. Official Gazette of the Republic of Slovenia. Regulations for requirements to be met by the laboratories working in cervical cytology (in Slovenian) vol. 68 (2001), Official Gazette of the Republic of Slovenia pp. 7033-37
22. Adab P., McGhee S.M., Yanova J., Wong C.M., and Hedley A.J. Effectiveness and efficiency of opportunistic cervical cancer screening. Comparison with organized screening. Med Care 42 (2004) 600-609
23. Mohan S., and Ind T. Cervical screening in England and Wales: an update. Curr Opin Obstet Gynecol 16 (2004) 491-496
24. Hadwin R.J., and Walker P.G. Quality control assurance in national screening programmes for cervical cancer. Ann Acad Med Singapore 32 (2003) 632-637
25. Žakelj-Primic M., and Repše-Fokter A. Cervical cancer screening: a Slovenian experience. Coll Antropol 31 Suppl. 2 (2007) 23-26